At Ibis Medical, product development begins with a clear clinical need, not with technology for its own sake. Our process typically moves through three practical stages—concept exploration, applied engineering, and controlled validation—with the aim of delivering devices that work reliably in everyday NICU conditions.
Inputs from neonatologists, nurses, biomedical engineers, and service teams play a key role at every stage. Feedback from hospitals across private and government sectors helps us define requirements, refine usability, and identify areas where incremental improvements can make a meaningful difference.
Where deeper technical evaluation is required, we collaborate with academic institutions such as NIT Calicut to strengthen engineering analysis and design decisions. This approach allows us to develop and improve products such as phototherapy systems, infant warmers, and neonatal accessories in a structured and practical manner.
Once a design is stabilised, it undergoes systematic testing and internal quality checks to ensure safety, performance, and repeatability. All development and manufacturing activities are carried out under ISO 13485–compliant processes and within the scope of our CDSCO manufacturing licences.
Our products are evaluated against applicable IEC safety and performance standards, including:
• IEC 60601-1 (General safety and essential performance)
• IEC 60601-2-21 (Infant warmers)
• IEC 60601-2-50 (Phototherapy equipment)
This disciplined approach helps ensure that products can be reliably scaled from prototype to regular production without compromising quality or serviceability.
Development at Ibis Medical does not stop at product launch. Field feedback, service observations, and usage data are reviewed continuously to guide upgrades, design refinements, and accessory improvements. This steady cycle of learning helps us improve long-term reliability, reduce avoidable complexity, and keep our installed base relevant over time.